Fundraising FoxCell Therapy Startups
5 companies tagged Cell Therapy, with their investors and founders.
Indee Labs develops a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to deliver nucleic acids, proteins, and gene editing complexes into patient and donor T cells. The technology targets T cell immunotherapy discovery, development, and manufacturing.
4 investors
Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
4 investors
LEAH Labs develops CAR-T cell therapy for pets, starting with dogs with B cell lymphoma, using a virus-free gene editing platform to produce engineered cell therapy doses at low cost. It targets general practice veterinarians across the USA, with a longer-term goal of extending its therapies to humans.
3 investors
WhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.
3 investors
Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.
1 investor